Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1b IV S-151128 Safety Study in Knee Osteoarthritis
jRCT2031230458Phase 1Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in knee osteoarthritis (OA) comparing S-151128 IV with Placebo IV (2 arms). Primary endpoint: Safety and tolerability of S-151128. Started Dec 2023; status: completed.
02
Drugs
S-151128
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on jRCT2031230458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230458.